Format

Send to

Choose Destination
See comment in PubMed Commons below
Urologe A. 2012 Oct;51(10):1356-61. doi: 10.1007/s00120-012-2993-4.

[Age and comorbidity in early prostate cancer].

[Article in German]

Author information

1
Klinik und Poliklinik für Urologie, Universitätsklinikum "Carl Gustav Carus", Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Deutschland. Michael.Froehner@uniklinikum-dresden.de

Abstract

With increasing age the risk-benefit balance of immediate curative treatment of early prostate cancer worsens. While the advantage of immediate intervention becomes increasingly uncertain the probability of unfavourable functional outcomes increases with an adverse impact on the quality of life. Therefore, a careful selection is particularly important in elderly patients with prostate cancer. For this purpose comorbidity classifications may be used; however up to now, there is no consensus on the instruments to be preferred and on the way of application. When different patient populations or clinical settings are considered the survival probabilities may differ significantly between patients with apparently identical levels of comorbidity. Therefore, when comorbidity classifications are intended to be used during treatment decision-making, it should be checked whether and how they are applicable in the individual clinical situation.

PMID:
23053029
DOI:
10.1007/s00120-012-2993-4
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center